Exact Sciences Corporatio... (EXAS)
Exact Sciences Statistics
Share Statistics
Exact Sciences has 185.75M shares outstanding. The number of shares has increased by 0.66% in one year.
| Shares Outstanding | 185.75M |
| Shares Change (YoY) | 0.66% |
| Shares Change (QoQ) | 0.37% |
| Owned by Institutions (%) | 99.53% |
| Shares Floating | 182.95M |
| Failed to Deliver (FTD) Shares | 3 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 10.66M, so 5.74% of the outstanding shares have been sold short.
| Short Interest | 10.66M |
| Short % of Shares Out | 5.74% |
| Short % of Float | 5.83% |
| Short Ratio (days to cover) | 3.62 |
Valuation Ratios
The PE ratio is -10.06 and the forward PE ratio is 71.43. Exact Sciences's PEG ratio is -0.03.
| PE Ratio | -10.06 |
| Forward PE | 71.43 |
| PS Ratio | 3.75 |
| Forward PS | 1.9 |
| PB Ratio | 4.31 |
| P/FCF Ratio | 138.84 |
| PEG Ratio | -0.03 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Exact Sciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.15, with a Debt / Equity ratio of 1.15.
| Current Ratio | 2.15 |
| Quick Ratio | 1.92 |
| Debt / Equity | 1.15 |
| Debt / EBITDA | -3.49 |
| Debt / FCF | 36.95 |
| Interest Coverage | -32.8 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $399.84K |
| Profits Per Employee | $-149.11K |
| Employee Count | 6,900 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 5.17 |
Taxes
| Income Tax | 7.3M |
| Effective Tax Rate | -0.71% |
Stock Price Statistics
The stock price has increased by -31.77% in the last 52 weeks. The beta is 1.14, so Exact Sciences's price volatility has been higher than the market average.
| Beta | 1.14 |
| 52-Week Price Change | -31.77% |
| 50-Day Moving Average | 47.33 |
| 200-Day Moving Average | 55.78 |
| Relative Strength Index (RSI) | 47.54 |
| Average Volume (20 Days) | 2.4M |
Income Statement
In the last 12 months, Exact Sciences had revenue of 2.76B and earned -1.03B in profits. Earnings per share was -5.59.
| Revenue | 2.76B |
| Gross Profit | 1.92B |
| Operating Income | -1.05B |
| Net Income | -1.03B |
| EBITDA | -789.33M |
| EBIT | -1B |
| Earnings Per Share (EPS) | -5.59 |
Balance Sheet
The company has 600.89M in cash and 2.75B in debt, giving a net cash position of -2.15B.
| Cash & Cash Equivalents | 600.89M |
| Total Debt | 2.75B |
| Net Cash | -2.15B |
| Retained Earnings | -4.5B |
| Total Assets | 5.93B |
| Working Capital | 1.09B |
Cash Flow
In the last 12 months, operating cash flow was 210.54M and capital expenditures -135.99M, giving a free cash flow of 74.55M.
| Operating Cash Flow | 210.54M |
| Capital Expenditures | -135.99M |
| Free Cash Flow | 74.55M |
| FCF Per Share | 0.4 |
Margins
Gross margin is 69.55%, with operating and profit margins of -38.01% and -37.29%.
| Gross Margin | 69.55% |
| Operating Margin | -38.01% |
| Pretax Margin | -37.03% |
| Profit Margin | -37.29% |
| EBITDA Margin | -28.61% |
| EBIT Margin | -38.01% |
| FCF Margin | 2.7% |
Dividends & Yields
EXAS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for EXAS is $67, which is 53.8% higher than the current price. The consensus rating is "Buy".
| Price Target | $67 |
| Price Target Difference | 53.8% |
| Analyst Consensus | Buy |
| Analyst Count | 21 |
Scores
| Altman Z-Score | 1.53 |
| Piotroski F-Score | 4 |